ISRCTN22497467已完成不适用
The biological variation of insulin resistance and cardiovascular risk factors in patients with non-alcoholic fatty liver disease compared to type 2 diabetes: an observational prospective study
Hull and East Yorkshire Hospitals NHS Trust (UK)0 个研究点目标入组 40 人开始时间: 2009年5月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •For both groups:
- •Both males and females, over age of 16 years
- •For NAFLD/non-alcoholic steatohepatitis (NASH) group:
- •1. Patients with confirmed NAFLD/NASH
- •2. Able to give informed consent
- •3. Agreeing to consent to inform GP's regarding participation in the study
- •4. No change in medication for 3 months prior to starting the study
- •For type 2 diabetes group:
- •1. Diabetes diagnosed according to World Health Organization (WHO) criteria
- •2. No change in medication for 3 months prior to starting study
排除标准
- •For NAFLD/NASH group:
- •1. Patients with concurrent illnesses
- •2. Patients not wishing to allow disclosure to their GP's
- •3. Alcohol intake more than 14 units/week for women, 21 units a week for men
- •4. Diabetic patients
- •5. Pregnancy or breastfeeding women
- •6. Smokers
- •For type 2 diabetes group:
- •1. Abnormal results from liver function tests (LFTs)
- •2. Patients with concurrent illnesses
- •3. Patients not wishing to allow disclosure to their GP's
- •4. Alcohol intake more than 14 units/week for women, 21 units a week for men
- •5. Pregnancy or breastfeeding women
- •6. Smokers
研究者
相似试验
已完成
不适用
Biological Variation of insulin resistance in normal ovulating women and PolyCystic Ovarian SyndromeISRCTN65353256Hull and East Yorkshire Hospitals NHS Trust (UK)40
已完成
不适用
Biological variation of insulin resistance, testosterone and cardiovascular risk factors in women with polycystic ovary syndrome: modification with rimonabant compared to metformiISRCTN75758249Hull and East Yorkshire Hospitals NHS Trust (UK)20
进行中（未招募）
1 期
Biological Variation of Insulin Resistance, Testosterone and Cardiovascular Risk Factors In Women with Polycystic Ovarian Syndrome: modification with Rimonabant compared to Metformin. - Rimonabant and Metformin in PCOSEUCTR2006-004447-35-GBHull and East Yorkshire Hospital Trust56
已完成
不适用
Exploring the effect of disturbance in insulin metabolism on the treatment response of hepatitis C virus to find options to improve response rateChronic viral hepatitisHepatitis C Virus (HCV) infectionInfections and InfestationsISRCTN64847145Imperial College London and Imperial College Healthcare NHS Trust (UK)22
已完成
不适用
The analysis of effects on insulin resistance and atherosclerotic risk factors before and after the treatment in patients with primary aldosteronism (PA)Primary aldosteronismJPRN-UMIN000002196Faculty of Life Sciences, Kumamoto University20